Back to search

Article

Precision Stratification: Kinase Assay in Asian <i>LRRK2</i> Risk Carriers and Idiopathic Parkinson Disease

2025-09-25

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Importance</h4> LRRK2 kinase inhibition is one of the most promising therapeutic strategies in Parkinson’s disease (PD), yet understanding of kinase activity in the Asian-prevalent p.G2385R and p.R1628P variants, each affecting 5–10% of PD patients, remains limited. Development of patient stratification and target engagement markers applicable across global cohorts is an urgent priority. <h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
003327be-c3db-51a6-9f48-f52f624965cd
DOI
10.1101/2025.09.23.25336067
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Precision Stratification: Kinase Assay in Asian <i>LRRK2</i> Risk Carriers and Idiopathic Parkinson DiseaseDOI 10.1101/2025.09.23.25336067
Select a neighboring publication to make it the new centre.